Portfolio company
ChainPeptides
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops synthetic antimicrobial peptides to treat chronic wounds and combat multi-drug resistant bacterial infections for healthcare providers and patients.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
DEBx Medical
This company develops chemical debridement agents for healthcare professionals to treat chronic wounds by removing infection and biofilm.
Omeza
This company develops marine-derived wound care products using fish peptides for healthcare providers treating patients with chronic or hard-to-heal skin ulcers.
MetalloBio
This company develops antimicrobial compounds and medical device coatings to combat antibiotic resistance for the pharmaceutical and healthcare sectors.
Peptilogics
This company develops engineered peptide therapeutics to treat and prevent medical device-related infections for patients undergoing joint replacements.
Amferia
This company produces antimicrobial hydrogel wound dressings for human healthcare and veterinary markets to combat antibiotic-resistant bacterial infections.
Adjutecpharma
This company develops antibiotic resistance breakers for healthcare providers to treat patients with life-threatening bacterial infections.
C10 PHARMA
This biopharmaceutical company develops novel antibiotics to treat life-threatening bacterial infections and combat antimicrobial resistance for patients with unmet medical needs.
AMR Bio
This biotechnology company develops topical antimicrobial gels to prevent post-surgical infections for healthcare providers and patients undergoing surgery.
